Search research articles
Contact Us
Filters
Showing results (11-20 of 104) with videos related to
Page
of 11
Sort By:
Cancer Journal (Sudbury, Mass.)
|
January 24, 2017
Novel Checkpoints and Cosignaling Molecules in Cancer Immunotherapy
Iulia Giuroiu, Jeffrey Weber
Journal of Gastrointestinal Oncology
|
December 4, 2012
Change of HER2 status in metastatic esophageal adenocarcinoma: heterogeneity of the disease? Case report and review of literature
Jiaxin Niu, Jeffrey Weber, Deborah Gelbspan
The New England Journal of Medicine
|
February 16, 2018
Adjuvant Therapy in Resected Melanoma
Jeffrey Weber, Anila Qureshi, Paolo A Ascierto
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons
|
December 29, 2019
Surgical Treatment of Subtalar Joint Instability: Safety and Accuracy of a New Technique in a Cadaver Model
Eric So, Jeffrey Weber, Gregory Berlet, et al.
Journal for Immunotherapy of Cancer
|
January 19, 2022
Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont <i>et al</i>
Jeffrey Weber, Mario Mandala, Paolo Antonio Ascierto, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2020
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity
Patrick Boland, Anna C Pavlick, Jeffrey Weber, et al.
Gastrointestinal Endoscopy
|
March 31, 2016
Successful endoscopic management of a malignant ileovesicular fistula
Toufic Kachaamy, Jeffrey Weber, David Weitz, et al.
The American Journal of Managed Care
|
January 26, 2015
Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting
Jeffrey Weber, Michael A Kolodziej, Daniel J George, et al.
The American Journal of Managed Care
|
January 26, 2015
Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting
Jeffrey Weber, Michael A Kolodziej, Daniel J George, et al.
International Immunology
|
August 5, 2009
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells
Wenshi Wang, Roy Lau, Daohai Yu, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 104) with videos related to
Sort By:
Page
of 11
Cancer Journal (Sudbury, Mass.)
|
January 24, 2017
Novel Checkpoints and Cosignaling Molecules in Cancer Immunotherapy
Iulia Giuroiu, Jeffrey Weber
Journal of Gastrointestinal Oncology
|
December 4, 2012
Change of HER2 status in metastatic esophageal adenocarcinoma: heterogeneity of the disease? Case report and review of literature
Jiaxin Niu, Jeffrey Weber, Deborah Gelbspan
The New England Journal of Medicine
|
February 16, 2018
Adjuvant Therapy in Resected Melanoma
Jeffrey Weber, Anila Qureshi, Paolo A Ascierto
The Journal of Foot and Ankle Surgery : Official Publication of the American College of Foot and Ankle Surgeons
|
December 29, 2019
Surgical Treatment of Subtalar Joint Instability: Safety and Accuracy of a New Technique in a Cadaver Model
Eric So, Jeffrey Weber, Gregory Berlet, et al.
Journal for Immunotherapy of Cancer
|
January 19, 2022
Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont <i>et al</i>
Jeffrey Weber, Mario Mandala, Paolo Antonio Ascierto, et al.
Journal for Immunotherapy of Cancer
|
April 19, 2020
Immunotherapy to treat malignancy in patients with pre-existing autoimmunity
Patrick Boland, Anna C Pavlick, Jeffrey Weber, et al.
Gastrointestinal Endoscopy
|
March 31, 2016
Successful endoscopic management of a malignant ileovesicular fistula
Toufic Kachaamy, Jeffrey Weber, David Weitz, et al.
The American Journal of Managed Care
|
January 26, 2015
Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting
Jeffrey Weber, Michael A Kolodziej, Daniel J George, et al.
The American Journal of Managed Care
|
January 26, 2015
Immunotherapy in cancer care: understanding the impact of shifting treatment paradigms in the managed care setting
Jeffrey Weber, Michael A Kolodziej, Daniel J George, et al.
International Immunology
|
August 5, 2009
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells
Wenshi Wang, Roy Lau, Daohai Yu, et al.
Page
of 11